Joshua C. Reisman

Mr. Reisman's experience includes representing:

• Opiant Pharmaceuticals, a clinical stage biopharmaceutical company developing new treatments for addiction and drug overdose, in its pending take-private sale to Indivior for up to US$213 million in upfront cash and contingent sales-based milestones
• New Relic in defense of a campaign by JANA Partners seeking board representation and governance changes
• New Relic in defense of a campaign by Engaged Capital seeking board representation and governance changes
• Silver Lake Partners in its US$500 million strategic investment in Shadowbox Studios
• Endeavor in the acquisition of multiple MLB Professional Development League Clubs, and the creation of Diamond Baseball Holdings
• Transfix in its US$1.1 billion merger with G Squared Ascend I (terminated)
• Aspiration in its pending US$2.3 billion merger with InterPrivate III Financial Partners
• Offerpad in its US$3 billion merger with Supernova Partners Acquisition Company
• Cyxtera Technologies in its US$3.4 billion merger with Starboard Value Acquisition Corp.
• Talkspace in its US$1.4 billion merger with Hudson Executive Investment Corp.
• Global Infrastructure Partners in the sale of Competitive Power Ventures to OPC Energy for US$630 million
• Hyundai Motor Group in its acquisition of an 80% interest in Boston Dynamics from SoftBank in a transaction valuing Boston Dynamics at US$1.1 billion
• Opendoor Labs in its US$4.8 billion merger with Social Capital Hedosophia Holdings II
• GCM Grosvenor in its US$2 billion merger with CF Finance Acquisition Corp.
• Cordelio Power, a subsidiary of CPPIB, in the acquisition of two wind development projects in Illinois having 350 MW capacity
• Kayne Anderson in the acquisition and tax equity financing of a utility-scale solar facility in North Carolina
• ConnectGen in the formation of a 50-50 joint venture and acquisition and tax equity financing of three utility-scale solar facilities in the Southwest US